admin

Biologic-based drugs have increasingly dominated the pharmaceutical market

A staggering 39 million people worldwide could succumb to antibiotic-resistant

Pharma 4.0 is a transformative approach in drug manufacturing

As we approach the fourth quarter of 2024, the global bio/pharma sector

As the pharmaceutical industry evolves and faces greater complexities,

API (Active Pharmaceutical Ingredient) manufacturing is a cornerstone

Cell and gene therapies represent an emerging frontier in bio/pharmaceutical

Pharmaceutical manufacturing faces numerous challenges that require

The World Health Organization (WHO) has declared the recent

In the ever-evolving world of global supply chains, certain companies